Page last updated: 2024-09-03

cholecystokinin (26-33), n-methyl-nle(28,31)- and morphinans

cholecystokinin (26-33), n-methyl-nle(28,31)- has been researched along with morphinans in 1 studies

Compound Research Comparison

Studies
(cholecystokinin (26-33), n-methyl-nle(28,31)-)
Trials
(cholecystokinin (26-33), n-methyl-nle(28,31)-)
Recent Studies (post-2010)
(cholecystokinin (26-33), n-methyl-nle(28,31)-)
Studies
(morphinans)
Trials
(morphinans)
Recent Studies (post-2010) (morphinans)
8003,251307648

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayres, EA; Burks, TF; Fang, S; Hruby, VJ; Kramer, TH; Parkhurst, DN1

Other Studies

1 other study(ies) available for cholecystokinin (26-33), n-methyl-nle(28,31)- and morphinans

ArticleYear
Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse.
    Proceedings of the Western Pharmacology Society, 1991, Volume: 34

    Topics: Amino Acid Sequence; Analgesics; Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Gastric Emptying; Gastrointestinal Transit; Indoles; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Peptide Fragments; Peptides; Phenylurea Compounds; Reaction Time; Receptors, Cholecystokinin; Sincalide

1991